Avinger to Announce Second Quarter 2017 Results on August 8, 2017
July 26 2017 - 04:01PM
Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative
treatments for peripheral artery disease (PAD), today announced
that it will release its financial results for the second quarter
of 2017 after the close of trading on Tuesday, August 8, 2017. The
Company will host a corresponding conference call beginning at
1:30pm PT/4:30pm ET.
Individuals interested in listening to the conference call may
do so by dialing (844) 776-7820 for domestic callers or (661)
378-9536 for international callers and referencing Conference ID:
58223692. To listen to a live webcast, please visit the investor
relations section of Avinger's website at: www.avinger.com.
A replay of the call will be available beginning August 8, 2017
at 4:30pm PT/7:30pm ET through 4:30pm PT/7:30pm ET on August 9,
2017. To access the replay, dial (855) 859-2056 or (404) 537-3406
and reference Conference ID: 58223692. The webcast will also be
available on Avinger's website for one year following the
completion of the call.
About Avinger, Inc. Founded in 2007, Avinger,
Inc. is a commercial-stage medical device company that designs and
develops the first-ever image-guided, catheter-based system that
diagnoses and treats patients with peripheral arterial disease
(PAD). Avinger is dedicated to radically changing the way vascular
disease is treated through their Lumivascular platform which
currently consists of the Lightbox imaging console, the Ocelot
family of catheters designed for chronic total occlusions (CTOs),
and Pantheris designed for atherectomy. Avinger is based in
Redwood City, CA. For more information, please visit
www.avinger.com.
Investor Contact:
Matt Ferguson
Avinger, Inc.
(650) 241-7917
ir@avinger.com
Avinger (NASDAQ:AVGR)
Historical Stock Chart
From Feb 2024 to Mar 2024
Avinger (NASDAQ:AVGR)
Historical Stock Chart
From Mar 2023 to Mar 2024